New Edge Advisors, LLC Cv Rx, Inc. Transaction History
New Edge Advisors, LLC
- $16 Billion
- Q4 2024
A detailed history of New Edge Advisors, LLC transactions in Cv Rx, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 415 shares of CVRX stock, worth $6,112. This represents 0.0% of its overall portfolio holdings.
Number of Shares
415Holding current value
$6,112% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CVRX
# of Institutions
94Shares Held
15.4MCall Options Held
76.5KPut Options Held
6.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$60.4 Million17.73% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$29.8 Million1.83% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT921KShares$13.6 Million1.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA910KShares$13.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$12.9 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $303M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...